📗 Cite This Artifact
Dorsal Root Ganglion Neurons in Chronic Neuropathic Pain
Dorsal Root Ganglion Neurons in Chronic Neuropathic Pain
Introduction
Dorsal Root Ganglion Neurons in Chronic Neuropathic Pain
Introduction
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Dorsal Root Ganglion Neurons in Chronic Neuropathic Pain</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4023189](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023189)</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Dorsal root ganglia (all spinal levels)</td>
</tr>
<tr>
<td class="label">Morphology</td>
<td>Pseudo-unipolar</td>
</tr>
<tr>
<td class="label">Diameter range</td>
<td>10-100 mum (size correlates with function)</td>
</tr>
<tr>
<td class="label">Myelination</td>
<td>Large: Abeta/Aalpha; Medium: Adelta; Small: Unmyelinated C</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Diameter</td>
</tr>
<tr>
<td class="label">Nociceptors</td>
<td>Small</td>
</tr>
<tr>
<td class="label">Mechanoreceptors</td>
<td>Large</td>
</tr>
<tr>
<td class="label">Thermoreceptors</td>
<td>Small</td>
</tr>
<tr>
<td class="label">Pruriceptors</td>
<td>Small</td>
</tr>
<tr>
<td class="label">Proprioceptors</td>
<td>Large</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Population</td>
</tr>
<tr>
<td class="label">Nav1.7 (SCN9A)</td>
<td>Nociceptors</td>
</tr>
<tr>
<td class="label">Nav1.8 (SCN10A)</td>
<td>Nociceptors</td>
</tr>
<tr>
<td class="label">Nav1.9 (SCN11A)</td>
<td>Nociceptors</td>
</tr>
<tr>
<td class="label">TRPV1</td>
<td>Peptidergic C</td>
</tr>
<tr>
<td class="label">TRPA1</td>
<td>Non-peptidergic</td>
</tr>
<tr>
<td class="label">TRPM8</td>
<td>Cold receptors</td>
</tr>
<tr>
<td class="label">CGRP</td>
<td>Peptidergic</td>
</tr>
<tr>
<td class="label">Substance P</td>
<td>Peptidergic</td>
</tr>
<tr>
<td class="label">IB4 binding</td>
<td>Non-peptidergic</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Molecular Basis</td>
</tr>
<tr>
<td class="label">Na+ channel upregulation</td>
<td>Nav1.3, Nav1.7, Nav1.8 increased</td>
</tr>
<tr>
<td class="label">K+ channel downregulation</td>
<td>KCNQ, KV reduced</td>
</tr>
<tr>
<td class="label">Ca2+ channel changes</td>
<td>Cav3.2 upregulation</td>
</tr>
<tr>
<td class="label">Receptor sensitization</td>
<td>TRPV1, TRPA1 phosphorylation</td>
</tr>
<tr>
<td class="label">Gene expression shifts</td>
<td>ATF3, c-Jun activation</td>
</tr>
<tr>
<td class="label">Gene Class</td>
<td>Changes</td>
</tr>
<tr>
<td class="label">Sodium channels</td>
<td>Nav1.3 up, Nav1.8 down, Nav1.9 down</td>
</tr>
<tr>
<td class="label">Potassium channels</td>
<td>KCNQ2/3 down, KV1.1/1.2 down</td>
</tr>
<tr>
<td class="label">Calcium channels</td>
<td>Cav3.2 up</td>
</tr>
<tr>
<td class="label">Neuropeptides</td>
<td>GAL up, NPY up, SP down, CGRP down</td>
</tr>
<tr>
<td class="label">Neurotrophin receptors</td>
<td>TrkA down, p75 up, Ret up</td>
</tr>
<tr>
<td class="label">Inflammatory mediators</td>
<td>TNF-alpha up, IL-1beta up, IL-6 up</td>
</tr>
<tr>
<td class="label">Transcription factors</td>
<td>ATF3 up, c-Jun up, STAT3 up</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">Nav1.7</td>
<td>PF-05089771, CNV1014802</td>
</tr>
<tr>
<td class="label">Nav1.8</td>
<td>Suzetrigine (VX-548)</td>
</tr>
<tr>
<td class="label">TRPV1</td>
<td>Capsaicin patch (high-concentration)</td>
</tr>
<tr>
<td class="label">TRPA1</td>
<td>GRC 17536</td>
</tr>
<tr>
<td class="label">Cav2.2</td>
<td>Ziconotide (intrathecal)</td>
</tr>
<tr>
<td class="label">alpha2delta subunits</td>
<td>Gabapentin, pregabalin</td>
</tr>
</table>
Dorsal root ganglion (DRG) neurons are the primary sensory neurons that transmit somatosensory information from peripheral tissues to the spinal cord. In chronic neuropathic pain states, these neurons undergo maladaptive plasticity including sensitization, ectopic firing, and altered gene expression, transforming from faithful sensory transducers into autonomous pain generators. Understanding DRG neuron dysfunction is essential for developing targeted analgesic therapies with improved efficacy and reduced central nervous system side effects.[@woolf2004][@scholz2019]
DRG neuron pathology also contributes to non-motor symptoms in neurodegenerative diseases including Parkinson's disease, where peripheral sensory dysfunction precedes motor symptoms, and in amyotrophic lateral sclerosis, where altered pain processing affects quality of life.
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
- Morphology: immature neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
External Database Links
- [Cell Ontology (CL:4023189)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023189)
- [OBO Foundry (CL:4023189)](http://purl.obolibrary.org/obo/CL_4023189)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
Neuroanatomy of DRG Neurons
Cellular Organization
DRG neurons are pseudo-unipolar neurons with a single axon that bifurcates into:
- Peripheral branch: Extends to skin, muscle, viscera
- Central branch: Enters dorsal horn via dorsal root
The cell bodies reside in the DRG, a cluster of neurons in the intervertebral foramen, protected by the blood-nerve barrier (less restrictive than the blood-brain barrier).
Functional Classification
DRG neurons are classified by function, size, and molecular markers:
Molecular Markers and Receptors
Normal Sensory Transduction
Peripheral Sensing
DRG neuron terminals express specialized transducer channels:
- Mechanosensitive channels: Piezo1, Piezo2, TREK1, TRAAK
- Thermosensitive channels: TRPV1-4, TRPM8, TRPA1
- Chemoreceptors: ASICs, P2X receptors
These channels convert physical/chemical stimuli into depolarizing receptor potentials, triggering action potential generation in the axon initial segment.
Action Potential Propagation
The unique pseudo-unipolar morphology allows "through-conduction"—action potentials bypass the soma during normal transmission, traveling directly from peripheral to central terminals. This efficiency is disrupted in neuropathic states.[@krames2015]
Neuropathic Pain Pathophysiology
Peripheral Sensitization
Following nerve injury, DRG neurons develop hyperexcitability through:
Ectopic Firing
Injured DRG neurons generate spontaneous action potentials without peripheral input:
- Ectopic pacemaker sites: Neuroma, DRG soma, T-junction
- Cross-excitation: Ephaptic coupling between neurons
- Afterdischarge: Prolonged firing after stimulus
This ectopic activity creates spontaneous pain (constant burning, aching) independent of peripheral stimuli.[@devor2009]
Central Sensitization Driver
Ectopic DRG firing drives spinal cord sensitization through:
- Glutamate release: AMPA/NMDA receptor activation
- Peptide release: Substance P, CGRP
- Microglial activation: ATP, fractalkine signaling
- Astrocyte activation: Cytokine release
Central sensitization amplifies all sensory input, producing allodynia (pain from non-painful stimuli) and hyperalgesia (enhanced pain from painful stimuli).
Gene Expression Changes in Neuropathy
Injury-Induced Transcriptional Reprogramming
Nerve injury triggers a cascade of transcriptional changes in DRG neurons:
Epigenetic Modifications
Chronic pain induces lasting epigenetic changes:
- DNA methylation: Persistent gene silencing
- Histone modifications: Chromatin remodeling
- Non-coding RNAs: miRNA-mediated translational regulation
These mechanisms contribute to pain chronicity and treatment resistance.[@denk2014]
Neuroinflammation in DRG
Immune Cell Infiltration
Following nerve injury, the DRG becomes infiltrated by:
- Macrophages: M1 pro-inflammatory phenotype
- T cells: CD4+ and CD8+ lymphocytes
- Neutrophils: Early after injury
These immune cells release pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) that directly sensitize DRG neurons.
Satellite Glial Cell Activation
Satellite glial cells (SGCs) envelop each DRG neuron and become activated in neuropathy:
- GFAP upregulation: Activation marker
- Gap junction formation: Interneuronal communication
- ATP/cytokine release: Paracrine sensitization
- Potassium buffering impairment: Neuronal hyperexcitability
SGC-neuron signaling creates a feed-forward sensitization loop.[@chen2023]
DRG in Neurodegenerative Diseases
Parkinson's Disease
Peripheral sensory dysfunction is an early feature of PD:
- Pain prevalence: 40-50% of PD patients report chronic pain
- Pre-motor symptom: May precede motor symptoms by years
- DRG pathology: α-synuclein accumulation reported
- Small fiber neuropathy: Reduced intraepidermal nerve fiber density
The sensory symptoms contribute significantly to reduced quality of life and are often undertreated.[@cury2016]
Amyotrophic Lateral Sclerosis
- DRG involvement: Sensory neuron pathology
- Altered pain processing: Both hypo- and hypersensitivity reported
- Quality of life impact: Pain affects 30-70% of ALS patients
- Mechanism uncertainty: May reflect central changes vs. peripheral
Diabetic Neuropathy Model
Diabetic peripheral neuropathy provides insights into metabolic contributions to neurodegeneration:
- Mitochondrial dysfunction: Energy failure in long axons
- Oxidative stress: ROS accumulation
- Advanced glycation end products: Protein cross-linking
- Shared mechanisms: Relevant to AD/PD metabolic hypotheses
Therapeutic Targeting of DRG
Pharmacological Approaches
Interventional Approaches
- DRG stimulation: Neuromodulation for refractory neuropathic pain
- Radiofrequency ablation: Targeted lesioning
- Botox injections: Chemodenervation
- Nerve blocks: Diagnostic and therapeutic
Gene Therapy Approaches
Emerging strategies targeting DRG:
- AAV-mediated gene delivery: Nav1.7 silencing, opioid receptor expression
- RNA interference: siRNA/shRNA knockdown of pain targets
- CRISPR-based approaches: Gene editing for hereditary pain disorders[@moren2024]
Diagnostic Evaluation
Functional Assessment
- Quantitative sensory testing (QST): Threshold determination
- Nerve conduction studies: Large fiber function
- Skin biopsy: Intraepidermal nerve fiber density
Biomarkers
- Serum neurofilament light: Axonal damage
- Inflammatory markers: CRP, cytokines
- miRNA profiles: Pain state signatures
Future Directions
Precision Pain Medicine
- Genetic profiling: SCN9A, CACNA1H variants
- Phenotyping: Sensory profiles guide treatment
- Biomarker panels: Predict treatment response
Novel Targets
- Mitochondrial function: DRG energy metabolism
- Satellite glial cells: Neuron-glia interactions
- Immune modulation: Targeting neuroinflammation
- Epigenetic therapy: Reversing maladaptive gene programs
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
Pathway Diagram
The following diagram shows the key molecular relationships involving Dorsal Root Ganglion Neurons in Chronic Neuropathic Pain discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | cell-types-drg-chronic-pain |
| kg_node_id | None |
| entity_type | cell |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-51e2e4171c2a |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-drg-chronic-pain'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-cell-types-drg-chronic-pain?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Dorsal Root Ganglion Neurons in Chronic Neuropathic Pain](http://scidex.ai/artifact/wiki-cell-types-drg-chronic-pain)
http://scidex.ai/artifact/wiki-cell-types-drg-chronic-pain